Skip to main content

Articles

Practice Management
Transforming the Drug Cost Paradigm from Payment for Medications to Payment for Value
Read More
Practice Management
Healthcare Utilization and Costs of Knee or Hip Replacements versus Pain-Relief Injections
Stakeholder Perspective
Knee and Hip Pain: Rewarding Optimal Long-Term Management
Read More
FDA Approvals
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder
Read More
FDA Approvals
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer
Read More
Introduction
The Continuing Clinical and Economic Burden of Cardiometabolic Health
Read More
Perspectives
Compensation for Managing Population Health
Read More
Original Research
Longitudinal Commercial Claims–Based Cost Analysis of Diabetic Retinopathy Screening Patterns
Stakeholder Perspective
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
Read More
Practice Management
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
Stakeholder Perspective
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Read More
Practice Management
The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes
Stakeholder Perspective
Saving Money Is Not Always the Objective
Read More
FDA Approvals
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Read More
Page 126 of 244
Results 1251 - 1260 of 2434